Back to Search
STEPHEN RAFFANTI, MD
MD
Infectious Disease Physician
NPI: 1285617332Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD0000020803(TN)
Research & Publications (20)
Effect of persistent moderate viremia on disease progression during HIV therapy.
PMID 15319674·J Acquir Immune Defic Syndr·2004
4-observational
Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPs.
PMID 19243231·AIDS Educ Prev·2009
4-observational
Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.
PMID 19220139·J Infect Dis·2009
8-other
Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators.
PMID 19108987·J Clin Epidemiol·2009
8-other
Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium.
PMID 19076107·Acad Emerg Med·2009
8-other
Potentially preventable tuberculosis among HIV-infected persons in the era of highly active antiretroviral treatment.
PMID 19275796·Int J Tuberc Lung Dis·2009
8-other
Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors.
PMID 19110909·J Natl Med Assoc·2008
8-other
Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures.
PMID 18922071·Clin Infect Dis·2008
8-other
Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIV.
PMID 18627280·AIDS Patient Care STDS·2008
8-other
Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
PMID 17763327·J Infect Dis·2007
8-other
Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.
PMID 17205482·J Infect Dis·2007
4-observational
Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity.
PMID 16912956·Clin Infect Dis·2006
8-other
CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
PMID 16107946·J Infect Dis·2005
8-other
Estimating the proportion of patients infected with HIV who will die of comorbid diseases.
PMID 16084183·Am J Med·2005
8-other
Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons.
PMID 15735444·J Acquir Immune Defic Syndr·2005
8-other
Oxidant stress is increased during treatment of human immunodeficiency virus infection.
PMID 14689356·Clin Infect Dis·2003
8-other
Two phases of HIV RNA decay in CSF during initial days of multidrug therapy.
PMID 14638961·Neurology·2003
3-trial
Improvements in access to care for HIV and AIDS in a statewide Medicaid managed care system.
PMID 14527105·Am J Manag Care·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3601 THE VANDERBILT CLINIC
NASHVILLE, TN 37232 - Phone
- (615) 322-3000
Quick Facts
- NPI
- 1285617332
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile